| scholarly article | Q13442814 |
| P50 | author | Makoto Ikeya | Q51952181 |
| Knut Woltjen | Q55135162 | ||
| Akitsu Hotta | Q55135226 | ||
| Satoshi Yamashita | Q55277911 | ||
| Emi Shoji | Q59679298 | ||
| Ken-Ichi Isobe | Q88354479 | ||
| En Kimura | Q45857305 | ||
| P2093 | author name string | Takuya Yamamoto | |
| Takumi Era | |||
| Nobuharu Fujii | |||
| Hidetoshi Sakurai | |||
| Yasuko Manabe | |||
| Atsuko Sehara-Fujisawa | |||
| Katsuya Miyake | |||
| Akihito Tanaka | |||
| Kazunori Hanaoka | |||
| Tokiko Nishino | |||
| P2860 | cites work | MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts | Q24297101 |
| Characterization of an acute muscle contraction model using cultured C2C12 myotubes | Q27324405 | ||
| A novel serum-free monolayer culture for orderly hematopoietic differentiation of human pluripotent cells via mesodermal progenitors | Q27331986 | ||
| Induced pluripotent stem cell lines derived from human somatic cells | Q27860597 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. | Q28131663 | ||
| Defective membrane repair in dysferlin-deficient muscular dystrophy | Q28203095 | ||
| Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy | Q28281738 | ||
| An ECM substratum allows mouse mesodermal cells isolated from the primitive streak to exhibit motility similar to that inside the embryo and reveals a deficiency in the T/T mutant cells | Q28295983 | ||
| Expression of a single transfected cDNA converts fibroblasts to myoblasts | Q29547764 | ||
| Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome | Q29616636 | ||
| Osteogenic properties of human myogenic progenitor cells. | Q50877137 | ||
| Efficient conversion of ES cells into myogenic lineage using the gene-inducible system. | Q51016287 | ||
| Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B | Q57990899 | ||
| The molecular basis of muscular dystrophy in the mdx mouse: a point mutation | Q69514522 | ||
| In vitro synthesis of light and heavy polypeptide chains of myosin | Q71585616 | ||
| Paraxial mesodermal progenitors derived from mouse embryonic stem cells contribute to muscle regeneration via differentiation into muscle satellite cells | Q81198385 | ||
| piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells | Q29619409 | ||
| Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene | Q34190227 | ||
| Plasticity of the differentiated state | Q34379462 | ||
| Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. | Q34420945 | ||
| Early expression of the myogenic regulatory gene, myf-5, in precursor cells of skeletal muscle in the mouse embryo | Q34500374 | ||
| MyoD directly up-regulates premyogenic mesoderm factors during induction of skeletal myogenesis in stem cells. | Q34509286 | ||
| Characterization of human embryonic stem cell lines by the International Stem Cell Initiative | Q34638055 | ||
| cDNA cloning and mapping of the human creatine kinase M gene to 19q13. | Q35198913 | ||
| Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice. | Q35947481 | ||
| MyoD induces myogenic differentiation through cooperation of its NH2- and COOH-terminal regions. | Q36320492 | ||
| Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish | Q36438833 | ||
| Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. | Q36482213 | ||
| Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation | Q36836682 | ||
| Diseases in a dish: modeling human genetic disorders using induced pluripotent cells | Q37965334 | ||
| Marked differences in differentiation propensity among human embryonic stem cell lines | Q40012772 | ||
| Derivation of engraftable skeletal myoblasts from human embryonic stem cells | Q40225312 | ||
| Immortalization of human myogenic progenitor cell clone retaining multipotentiality | Q40242035 | ||
| Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. | Q41080686 | ||
| Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation | Q41136531 | ||
| Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. | Q41985465 | ||
| Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. | Q42819955 | ||
| Enhanced differentiation of human embryonic stem cells to mesenchymal progenitors by inhibition of TGF-beta/activin/nodal signaling using SB-431542. | Q43143526 | ||
| Myogenic differentiation by human processed lipoaspirate cells. | Q46007937 | ||
| mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo | Q46055034 | ||
| Mesp2: a novel mouse gene expressed in the presegmented mesoderm and essential for segmentation initiation | Q48047260 | ||
| Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy. Seventeen cases in eight families including an autopsied case | Q48380264 | ||
| A new model mouse for Duchenne muscular dystrophy produced by 2.4 Mb deletion of dystrophin gene using Cre-loxP recombination system | Q49076566 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | reproducibility | Q1425625 |
| P304 | page(s) | e61540 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro | |
| P478 | volume | 8 |
| Q64969794 | (Epi)genetic Modifications in Myogenic Stem Cells: From Novel Insights to Therapeutic Perspectives. |
| Q59808353 | A Myogenic Double-Reporter Human Pluripotent Stem Cell Line Allows Prospective Isolation of Skeletal Muscle Progenitors |
| Q30824665 | A Novel Protocol for Directed Differentiation of C9orf72-Associated Human Induced Pluripotent Stem Cells Into Contractile Skeletal Myotubes |
| Q42677230 | A Skeletal Muscle Model of Infantile-onset Pompe Disease with Patient-specific iPS Cells |
| Q28539525 | A novel strategy for enrichment and isolation of osteoprogenitor cells from induced pluripotent stem cells based on surface marker combination |
| Q89842749 | AMPK Complex Activation Promotes Sarcolemmal Repair in Dysferlinopathy |
| Q94487112 | Acute conversion of patient-derived Duchenne muscular dystrophy iPSC into myotubes reveals constitutive and inducible over-activation of TGFβ-dependent pro-fibrotic signaling |
| Q92494786 | Assessment of different strategies for scalable production and proliferation of human myoblasts |
| Q91767685 | CRISPR-Cas3 induces broad and unidirectional genome editing in human cells |
| Q26777415 | Cell-Penetrating Peptide as a Means of Directing the Differentiation of Induced-Pluripotent Stem Cells |
| Q39368114 | Cellular Reprogramming, Genome Editing, and Alternative CRISPR Cas9 Technologies for Precise Gene Therapy of Duchenne Muscular Dystrophy |
| Q36904682 | Clinical Trials in a Dish: The Potential of Pluripotent Stem Cells to Develop Therapies for Neurodegenerative Diseases |
| Q91899809 | Coding Cell Identity of Human Skeletal Muscle Progenitor Cells Using Cell Surface Markers: Current Status and Remaining Challenges for Characterization and Isolation |
| Q92230299 | Core Transcription Factors Promote Induction of PAX3-Positive Skeletal Muscle Stem Cells |
| Q54987739 | Current Progress and Challenges for Skeletal Muscle Differentiation from Human Pluripotent Stem Cells Using Transgene-Free Approaches. |
| Q34542838 | Derivation of human differential photoreceptor cells from adult human dermal fibroblasts by defined combinations of CRX, RAX, OTX2 and NEUROD. |
| Q50067732 | Differentiation and sarcomere formation in skeletal myocytes directly prepared from human induced pluripotent stem cells using a sphere-based culture. |
| Q41002189 | Differentiation of control and ALS mutant human iPSCs into functional skeletal muscle cells, a tool for the study of neuromuscolar diseases |
| Q28265827 | Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy |
| Q64089061 | Directed Differentiation of Pluripotent Stem Cells by Transcription Factors |
| Q34652434 | Dual gene expression in embryoid bodies derived from human induced pluripotent stem cells using episomal vectors |
| Q27308743 | Early pathogenesis of Duchenne muscular dystrophy modelled in patient-derived human induced pluripotent stem cells. |
| Q45876520 | Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells. |
| Q48204589 | Efficient differentiation of human pluripotent stem cells into skeletal muscle cells by combining RNA-based MYOD1-expression and POU5F1-silencing. |
| Q92715308 | Emerging opportunities for induced pluripotent stem cells in orthopaedics |
| Q49165157 | Engineering human pluripotent stem cells into a functional skeletal muscle tissue |
| Q41019331 | Engineering the AAVS1 locus for consistent and scalable transgene expression in human iPSCs and their differentiated derivatives. |
| Q30837631 | Enhanced Development of Skeletal Myotubes from Porcine Induced Pluripotent Stem Cells. |
| Q36442713 | Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes |
| Q39296894 | Epigenetic Manipulation Facilitates the Generation of Skeletal Muscle Cells from Pluripotent Stem Cells |
| Q33905388 | Expansion and Purification Are Critical for the Therapeutic Application of Pluripotent Stem Cell-Derived Myogenic Progenitors |
| Q90316691 | Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping |
| Q28076485 | From pluripotency to myogenesis: a multistep process in the dish |
| Q47155111 | Functional validation and expression analysis of myotubes converted from skin fibroblasts using a simple direct reprogramming strategy |
| Q53094351 | Generation of Equine-Induced Pluripotent Stem Cells and Analysis of Their Therapeutic Potential for Muscle Injuries. |
| Q38748704 | Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro |
| Q38510396 | Generation of skeletal muscle cells from pluripotent stem cells: advances and challenges |
| Q37589752 | Genome Editing Gene Therapy for Duchenne Muscular Dystrophy. |
| Q90929514 | Genome-wide microhomologies enable precise template-free editing of biologically relevant deletion mutations |
| Q39072413 | HPGCD outperforms HPBCD as a potential treatment for Niemann-Pick disease type C during disease modeling with iPS cells. |
| Q38321965 | Human artificial chromosomes for Duchenne muscular dystrophy and beyond: challenges and hopes. |
| Q90327070 | Human iPSC Models to Study Orphan Diseases: Muscular Dystrophies |
| Q64069475 | Human induced pluripotent stem cell models for the study and treatment of Duchenne and Becker muscular dystrophies |
| Q92378308 | Identification of new transmembrane proteins concentrated at the nuclear envelope using organellar proteomics of mesenchymal cells |
| Q37410916 | Identification of transcription factors for lineage-specific ESC differentiation. |
| Q88479019 | In Vitro Tissue-Engineered Skeletal Muscle Models for Studying Muscle Physiology and Disease |
| Q60908818 | Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy |
| Q39040578 | Induced pluripotent stem cell technology: a decade of progress |
| Q38869452 | Inducible Transgene Expression in Human iPS Cells Using Versatile All-in-One piggyBac Transposons |
| Q33559698 | Inducible and Deterministic Forward Programming of Human Pluripotent Stem Cells into Neurons, Skeletal Myocytes, and Oligodendrocytes |
| Q36945218 | Minireview: Genome Editing of Human Pluripotent Stem Cells for Modeling Metabolic Disease. |
| Q57167748 | Modeling human somite development and fibrodysplasia ossificans progressiva with induced pluripotent stem cells |
| Q33573651 | Myogenic Differentiation from MYOGENIN-Mutated Human iPS Cells by CRISPR/Cas9. |
| Q26799633 | Myogenic Precursors from iPS Cells for Skeletal Muscle Cell Replacement Therapy |
| Q41956611 | Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery |
| Q30838313 | Myotonic dystrophy type 1 patient-derived iPSCs for the investigation of CTG repeat instability. |
| Q93098955 | Phenotypic Drug Screening for Dysferlinopathy Using Patient-Derived Induced Pluripotent Stem Cells |
| Q89560779 | Possible application of muscle specific conditional mouse-derived induced pluripotent stem cells for muscle research |
| Q98726590 | Potential of transposon-mediated cellular reprogramming towards cell-based therapies |
| Q36951286 | Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy |
| Q41873090 | Precise correction of the dystrophin gene in duchenne muscular dystrophy patient induced pluripotent stem cells by TALEN and CRISPR-Cas9. |
| Q52560156 | Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors. |
| Q36071259 | Primary Human Uterine Leiomyoma Cell Culture Quality Control: Some Properties of Myometrial Cells Cultured under Serum Deprivation Conditions in the Presence of Ovarian Steroids. |
| Q91910365 | RNA Virus-Based Episomal Vector with a Fail-Safe Switch Facilitating Efficient Genetic Modification and Differentiation of iPSCs |
| Q89093199 | Recapitulating muscle disease phenotypes with myotonic dystrophy 1 induced pluripotent stem cells: a tool for disease modeling and drug discovery |
| Q41851786 | Regeneration: making muscle from hPSCs |
| Q37589437 | Role of mesenchymal stem cells in cell life and their signaling |
| Q36059427 | Screening of Human cDNA Library Reveals Two differentiation-Related Genes, HHEX and HLX, as Promoters of Early Phase Reprogramming toward Pluripotency |
| Q64227851 | Simplified in vitro engineering of neuromuscular junctions between rat embryonic motoneurons and immortalized human skeletal muscle cells |
| Q39321274 | Skeletal Muscle Cell Induction from Pluripotent Stem Cells |
| Q33854768 | Skeletal muscle generated from induced pluripotent stem cells - induction and application |
| Q38577279 | Stem Cell Differentiation Toward the Myogenic Lineage for Muscle Tissue Regeneration: A Focus on Muscular Dystrophy |
| Q36874154 | Synergizing Engineering and Biology to Treat and Model Skeletal Muscle Injury and Disease. |
| Q42365991 | TFEB overexpression promotes glycogen clearance of Pompe disease iPSC-derived skeletal muscle |
| Q58719281 | The Importance of Biophysical and Biochemical Stimuli in Dynamic Skeletal Muscle Models |
| Q64112074 | The impact of transposable element activity on therapeutically relevant human stem cells |
| Q89543326 | The mesenchymoangioblast, mesodermal precursor for mesenchymal and endothelial cells |
| Q33678893 | Therapy of Genetic Disorders-Novel Therapies for Duchenne Muscular Dystrophy |
| Q41512207 | Three-Dimensional Culture Model of Skeletal Muscle Tissue with Atrophy Induced by Dexamethasone |
| Q37381245 | Transient ectopic expression of the histone demethylase JMJD3 accelerates the differentiation of human pluripotent stem cells. |
| Q38185513 | iPS cells: a game changer for future medicine |
| Q90167832 | iPSC-derived functional human neuromuscular junctions model the pathophysiology of neuromuscular diseases |
| Q61806874 | iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies |
| Q36330999 | piggyBac-ing models and new therapeutic strategies |
Search more.